This study is an exploration of developments in "green" (plant) biotechnology for the purpose of policy development and updating risk assessment of GMOs and biotechnology in general in the Netherlands. The study is based on a literature review and interviews with stakeholders. The developments encompass both novel techniques such as genome editing and new concepts or applications for already established techniques such as plant transformation (transgenic plants). Intended and unintended effects are discussed, but risk assessment and regulatory issues are not, since they are out of the scope of this inventory.